Alteration of flow-induced dilatation in mesenteric resistance arteries of L-NAME treated rats and its partial association with induction of cyclo-oxygenase-2

British Journal of Pharmacology

Volumn 121, Issue 1, 1997, Pages 83-90

  Henrion, Daniel ^a,c   Dechaux, Elsa ^a   Dowell, Fiona J ^a   Maclour, Jacques ^c   Samuel, Jane Lise ^b   Lévy, Bernard I ^a   Michel, Jean Baptiste ^a  

^a INSERM   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c HÔPITAL LARIBOISIÈRE   (France)

Author keywords

Angiotensin I converting enzyme inhibitors; Cyclo oxygenase; L NAME; Myogenic tone; Resistance arteries; Shear stress; Vascular reactivity

Indexed keywords

ARGININE METHYL ESTER; CYCLOOXYGENASE 2; ICATIBANT; INDOMETACIN; N (2 CYCLOHEXYLOXY 4 NITROPHENYL)METHANESULFONAMIDE; PROSTACYCLIN; PROSTAGLANDIN F2 ALPHA; QUINAPRIL;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTERY BLOOD FLOW; ARTERY DILATATION; ARTICLE; CONTROLLED STUDY; MALE; MEAN ARTERIAL PRESSURE; MESENTERIC ARTERY; NONHUMAN; PRIORITY JOURNAL; RAT; RESISTANCE BLOOD VESSEL;

EID: 0030978689     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0701109     Document Type: Article

References (51)

1. ARNAL, J.F., EL AMRANI, A.I., CHATELLIER, G., MÉNARD, J. & MICHEL, J.B. (1993). Cardiac weight in hypertension induced by nitric oxide blockade. Hypertension, 22, 308 - 387.
2. ARNAL, J.F., WARIN, L. & MICHEL, J.B. (1992). Determinant of aortic cyclic guanosine monophosphate in hypertension induced by chronic inhibition of nitric oxide synthase. J. Clin. Invest., 90, 647 - 652.
3. BARNARD, J.W., WILSON, P.S., MOOR, T.M., THOMPSON, W.J. & TAYLOR, A.E. (1993). Effects of nitric oxide and cyclooxygenase products on vascular resistance in dog and rat lungs. J. Appl. Physiol., 74, 2940 - 2948.
4. BAYLIS, C., MITRUKA, B. & DENG, A. (1992). A chronic blockade of nitric oxide synthesis in the rat produces systemic hypertension and glomerular damages. J. Clin. Invest., 90, 278 - 281.
5. BEVAN, J.A. & HENRION, D. (1994). Pharmacological implications of the influence of intraluminal flow on smooth muscle tone. Annu. Rev. Pharmacol. Toxicol., 34, 173 - 190.
6. BEVAN, J.A. & LAHER, I. (1991). Pressure and flow-dependent vascular tone. FASEB J., 5, 2267 - 2273.
7. BRUNNER, H.R., NUSSBERGER, J., BURNIER, M & WAEBER, B. (1993). Angiotensin II antagonists. Clin. Exp. Hypertens., 15, 1221 - 1238.
8. BUSSE, R. & LAMONTAGNE, D. (1991). Endothelium derived bradykinin is responsible for the increase in calclium produced by angiotensin-converting enzyme inhibitors in human endothelial cells. Naunyn-Schmiedeberg's. Arch. Pharmacol., 344, 126 - 129.
9. CRÉMINON, C., HABIB, A., MACLOUF, J., PRADELLES, P., GRASSI, J. & FROBERT, Y. (1995). Differential measurement of constitutive (COX-1) and inducible (COX-2) cycloxygenase expression in human umbilical vein endothelial cells using specific immunometric enzyme immunoassays. Biochem. Biophys. Acta, 1254, 341 - 348.
10. D'ANGELO, G. & MEININGER, G.A. (1994). Transduction mechanisms involved in the regulation of myogenic tone activity. Hypertension, 23, 1096 - 1105.
11. DAVIES, P.F. & TRIPATHI, S.C. (1993). Mechanical stress mechanisms and the cell. An endothelial paradigm. Circ. Res., 72, 239 - 245.
12. DOWELL, F.J., HENRION, D., DURIEZ, M. & MICHEL, J.B. (1996). Vascular reactivity in mesenteric resistance arteries following chronic nitric oxide synthase inhibition in Wistar rats. Br. J. Pharmacol., 117, 341 - 346.
13. FALCONE, J.C., GRANGER, H.J. & MEININGER, G.A. (1993). Enhanced myogenic activation in skeletal muscle arterioles from spontaneously hypertensive rats. Am. J. Physiol., 265, H1847 - H1855.
14. 2 receptor antagonist. Hoe 140, in isolated blood vessesls from different species. Br. J. Pharmacol., 112, 683 - 689.
15. FITZGERALD, G.A., OATES, J.A., HAWIGER, J., MAAS, R.L., ROBERTS, L.J., LAWSON, J.A. & BRASH. A.R. (1983). Endogenous biosynthesis of prostacyclin and thromboxane and platelet function during chronic administration of aspirin in man. J. Clin. Invest., 71, 676 - 688.
16. FORD, D.A. & GROSS, R.W. (1989). Plasmenylethanolamine is the major storage depot for arachidonic acid in rabbit vascular smooth muscle and is rapidly hydrolyzed after angiotensin II stimulation. Proc. Natl. Acad. Sci. U.S.A., 86, 3479 - 3483.
17. FUTAKI, N., TAKAHASHI, S., YOKOYAMA, M., AVAI, I., HIGUCHI. S. & OTOMO, S. (1994). NS 398, a new antiinflamatory agent, selectively inhibits G/H synthase/cyclooxygenase (COX-2) activity in vitro. Prostaglandins, 47, 55 - 59.
18. FURCHGOTT, R.F. & VANHOUTTE, P.M. (1991). Endothelium derived relaxing and contracting factors. FASEB J., 344, 126 - 129.
19. HABIB, A., CRÉMINON, C., EROBERT, Y., GRASSI, J., PRADELLES, P. & MACLOUF, J. (1994). Demonstration of an inducible cyclooxygenase in human endothelial cells using antibodies raised against the C-terminal region of the cycloogenase-2. J. Biol. Chem., 268, 23448 - 23454.
20. HALPERN, W., OSOL, G. & COY, G.S. (1984). Mechanical behavior of pressurized in vitro prearteriolar vessels determined with a video system. Ann. Biomed. Ing., 12, 463-479.
21. HECKER, M., MULSCH, A., BASSENGE, E. & BUSSE, R. (1993). Vasoconstriction and increased flow: two principal mechanisms of shear stress-dependent endothelial autacoid release. Am. J. Physiol., 265, H828 - H833.
22. G-nitro-L-arginine methyl ester. Hypertension, 28, 361 - 366.
23. 2+ influx in the rabbit facial vein. Circ. Res., 71, 339-345.
24. HOLTZ, J. & GOETZ, R.M. (1994). Vascular renin-angiotensin-system. endothelial function and atherosclerosis? Basic. Res. Cardiol., 89, (S.I), 71-86.
25. JOHNSON, P.C. (1991). The myogenic response. In The Resistance Vasculature. ed Bevan, J.A., Halpern, W. & Mulvany, M.J. pp. 159 - 168. Totowa, New Jersey: Humana Press.
26. KOLLER, A. & HUANG, A. (1994). Impaired nitric oxide-mediated flow-induced dilation in arterioles of spontaneously hypertensive rats. Cir. Res., 74, 416 - 421.
27. KOLLER, A., SUN, D. & KALEY, G. (1993). Role of shear stress and endothelial prostaglandins in flow and viscosity induced dilation of arterioles in vitro. Circ. Res., 72, 1276 - 1284.
28. KUO, L., DAVIS, M.J. & CHILLIAN, W.M. (1992). Endothelial modulation of arteriolar tone. News Physiol. Sci., 7, 5 - 9.
29. KUO, L., WILLIAM, M.C. & DAVIS, M.J. (1991). Interaction of pressure- and flow-induced responses in porcine coronary resistance vessels. Am. J. Physiol., 261, H1706 - H1715.
30. 2+-dependent stretch-induced vascular tone. Biochem. Biophys. Res. Commun., 158, 58 - 62.
31. 2 and prostacyclin. Prostaglandins, 40, 297 - 310.
32. MOMBOULI, J.V., ILIANO, S., NAGAO, T., SCOTT-BURDEN, T. & VANHOUTTE, P.M. (1992). Potentiation of endothelium-dependent relaxations to bradykinin by angiotensin I converting enzyme inhibitors in canine coronary artery involves both endothelium-derived relaxing and hyperpolarizing factors. Circ. Res., 71, 137 - 144.
33. MONCADA, S. & HIGGS, E.A. (1993). The L-arginine-nitric oxide pathway. New Engl. J. Med., 329, 2002 - 2012.
34. MONCADA, S., PALMER, R.M.J. & HIGGS, E.A. (1991). Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev., 43, 109 - 142.
35. OSOL, G. (1991). Myogenic properties of blood vessels in vitro. In The Resistance Vasculature. ed. Bevan, J.A., Halpern, W. & Mulvany, M.J. pp. 143 - 157. Totowa, New Jersey: Humana Press.
36. PFEILSCHIFTER, J. & BAUER, C. (1986). Pertussis toxin abolishes angiotensin II-induced phosphoinositide hydrolysis and prostaglandins synthesis in rat mesangial cells. Biochem. J., 236, 289 - 294.
37. POLLOCK, D.M., POLAKOWSKI, J.S., DIVISH, B.J. & OPGENORTH. T.J. (1993). Angiotensin blockade reverses hypertension during long-term nitric oxide synthesis inhibition. Hypertension, 21, 660 - 666.
38. QIU, C.B., ENGELS, K. & BAYLISS, C. (1994). Angiotensin II and alpha(1)-adrenergic tone in chronic nitric oxide blockade-induced hypertension. Am. J. Physiol., 266, R1470 - R1476.
39. RIBEIRO, M.O., ANTUNES. E., DE NUCCI, G., LOVISOLO, S.M. & ZATS. R. (1992). Chronic inhibition of nitric oxide synthesis, a new model of arterial hypertension. Hypertension. 20, 298 - 303.
40. RIMARACHIN, J.A., JACOBSON, J.A., SZABO, P., MACLOUF, J., CRÉMINON, C. & WEKSLER, B.B. (1994). Regulation of cyclooxygenase-2 expression in aortic smooth muscle cells. Arterioscler. Thromb., 14, 1021 - 1031.
41. SEGAL, S.S. (1994). Cell-to-cell communication coordinates blood flow control. Hypertension, 23, 1113 - 1120.
42. SIGMON, D.H. & BEIERWALTES, W.H. (1993). Angiotensin II: nitric oxide interaction and the distribution of flow. Am. J. Physiol., 265, R1276 - R1283.
43. SMIESKO, V. & JOHNSON, P.C. (1993). The arterial lumen is controlled by flow-related shear stress. News Physiol. Sci., 8, 34 - 38.
44. SWIERKOSZ, T.A., MITCHELL, J.A., WARNER, T.D., BOTTINGJ, R.M. & VANE, J.R. (1995). Co-induction of nitric oxide synthase and cyclo-oxygenase: interactions between nitric oxide and prostanoids. Br. J. Pharmacol., 114, 1335 - 1342.
45. UNGER, T. & LEBRUN, C.J. (1992). Cardioprotection and converting enzyme inhibition role of bradykinins. Diabeta Metab., 18, 161 - 169.
46. 2α production. cyclooxygenase activity, and cell growth by a pertussis toxin sensitive mechanism. J. Cell. Physiol., 163, 285 - 294.
47. VANHOUTTE, P.M., HAUCH-SCHWELKE. W., BONDI, M.L., LORENZ, R.R., SCHINI, V.B. & VIDAL, M.J. (1989). Why are converting enzyme inhibitors vasodilators? Br. J. Clin. Pharmacol., 28, 95S-104S.
48. WIEMER, G., SCHÖLKENS, B.A., BECKER, R.M.A. & BUSSE, R. (1991). Ramiprilat enhances endothelial autacoids formation by inhibiting breakdown of endothelial derived bradykinin. Hypertension, 18, 558 - 563.
49. WIEMER, G., SCHÖLKENS, B.A. & LING, W. (1994). Endothelial protection by converting enzyme inhibitors. Cardiovasc. Res., 28, 166 - 172.
50. XU, Y., ARNAL, J.F., HINGLANIS, N., APPAY, M.D., LABOULANDINE, I., BARIETY, J. & MICHEL, J.B. (1995). Renal hypertensive angiopathy. Comparison between chronic NO suppression and DOCA-salt intoxication. Am. J. Hypertens., 8, 167 - 176.
51. ZANCHI, A., SCHAAD, S.C., OSTERHELD, M.C., GROUZMANN, E., NUSSBERGER, J., BRUNNER, H.R. & WAEBER, B. (1995). Effects of chronic NO synthase inhibition on renin-angiotensin system and sympathetic nervous system. Am. J. Physiol., 268, H2267 - H2273.